YOR329W-A is a putative uncharacterized protein encoded by the YOR329W-A gene in Saccharomyces cerevisiae. Despite its classification as a "smORF" (small Open Reading Frame) or uncharacterized protein, recombinant production systems have enabled its study, though functional roles remain elusive. This article synthesizes available data on its structural features, recombinant production methods, and potential biological relevance.
YOR329W-A is commercially available as recombinant protein and polyclonal antibodies (anti-YOR329W-A) . Key applications include:
Antibody Production: Rabbit-derived polyclonal antibodies are used for ELISA and Western blotting .
Functional Studies: While no functional data exist, its recombinant form enables hypothesis-driven experiments (e.g., subcellular localization, interaction assays).
Product Type | Host | Purity | Applications |
---|---|---|---|
Recombinant Protein | E. coli/Yeast | ≥85% (SDS-PAGE) | ELISA, Western blotting |
Cell-Free Expression System | In vitro | ≥85% (SDS-PAGE) | Structural studies |
Polyclonal Antibody | Rabbit | Affinity-purified | Immunodetection |
Expression Data: No expression profiles are available in S. cerevisiae, as indicated by the Saccharomyces Genome Database (SGD) .
Functional Hypotheses:
Limited Functional Data: No peer-reviewed studies on catalytic activity, interactions, or phenotypic effects.
Ambiguous Classification: Designated as "uncharacterized" due to insufficient experimental validation.
While YOR329W-A lacks direct homologs, its potential vacuolar localization parallels other S. cerevisiae proteins:
Proteinase A: A vacuolar aspartic protease essential for hydrolase activation .
NMN Adenylyltransferase (YLR328W): Catalyzes NAD synthesis, with structural and functional data established .
To elucidate YOR329W-A’s role, prioritize:
High-Throughput Screening: Use CRISPR knockout/mutant libraries to identify phenotypic changes.
Proteomic Interactomes: Co-IP/mass spectrometry to map interactions with vacuolar or retrotransposon-related proteins.
Structural Studies: X-ray crystallography or cryo-EM to determine 3D structure and active sites.
YOR329W-A is a putative uncharacterized protein from Saccharomyces cerevisiae (baker's yeast), a model organism extensively used in molecular and cellular biology research. This protein consists of 69 amino acids with the sequence: MFRYHVKFIEPAMIYKILANEKMQIIWVLNSYFEFYLLFCPRFLMLTLFLIGATYFCFLIWRKKVSRNK . The significance of studying this protein lies in the fact that S. cerevisiae was the first yeast to have its entire genome sequenced, making it an invaluable model for understanding eukaryotic cellular processes. Uncharacterized proteins like YOR329W-A represent knowledge gaps in our understanding of yeast biology, and characterizing them could reveal novel cellular mechanisms, pathways, or functions that may have implications for broader eukaryotic biology. Research on such proteins contributes to completing the functional annotation of the yeast genome and potentially unveils new biotechnological applications .
While YOR329W-A remains uncharacterized, its study should be approached through comparative analysis with known proteins. Using bioinformatics tools for sequence alignment, domain prediction, and phylogenetic analysis can reveal potential functional relationships with characterized proteins. Current research suggests that putative proteins like YOR329W-A may be involved in stress responses, membrane functioning, or cell cycle regulation based on expression patterns during different growth phases of S. cerevisiae. Methodologically, researchers should employ multiple sequence alignment tools (such as BLAST and Clustal Omega) to identify conserved domains, followed by co-expression analysis to identify genes with similar expression patterns, which may indicate functional relationships or pathway involvement .
E. coli expression systems are commonly used for producing recombinant YOR329W-A protein, particularly with N-terminal His-tags to facilitate purification . For methodological implementation, researchers should:
Clone the YOR329W-A gene into a suitable expression vector (pET series vectors work well)
Transform into a compatible E. coli strain (BL21(DE3) is frequently effective)
Optimize expression conditions:
IPTG concentration: 0.1-1.0 mM
Induction temperature: 16-37°C (lower temperatures may improve solubility)
Induction duration: 4-18 hours
Alternative expression systems to consider include yeast-based systems (particularly S. cerevisiae itself or Pichia pastoris) when post-translational modifications might be important for functional studies. Each system requires specific optimization strategies focused on codon optimization, induction parameters, and purification approaches .
Based on current research, optimal storage and handling protocols for YOR329W-A protein include:
Storage Parameter | Recommended Condition | Notes |
---|---|---|
Temperature | -20°C/-80°C | Aliquoting necessary for multiple use |
Buffer Composition | Tris/PBS-based buffer, 6% Trehalose, pH 8.0 | Maintains structural integrity |
Reconstitution | Deionized sterile water (0.1-1.0 mg/mL) | Add 5-50% glycerol (final concentration) |
Handling Caution | Avoid repeated freeze-thaw cycles | Working aliquots can be stored at 4°C for up to one week |
For long-term storage, adding glycerol to a final concentration of 50% before aliquoting and storing at -80°C is recommended. When working with the protein, centrifuge vials briefly before opening to ensure contents are at the bottom, and minimize exposure to room temperature to prevent degradation .
To confirm the identity of recombinant YOR329W-A protein, researchers should implement a multi-method characterization approach:
SDS-PAGE analysis: Confirms protein size (expected ~7.7 kDa plus tag size) and purity (should exceed 90%)
Western blotting: Using anti-His antibodies to verify tagged protein expression
Mass spectrometry (MS):
MALDI-TOF for molecular weight confirmation
LC-MS/MS for peptide mapping and sequence verification
N-terminal sequencing: To confirm the correct starting sequence
Circular dichroism (CD): To assess secondary structure elements
These techniques collectively provide confirmation of protein identity, purity, and basic structural characteristics. For uncharacterized proteins like YOR329W-A, thorough characterization is particularly important before proceeding to functional studies. Documentation should include gel images, MS spectra, and sequence confirmation reports to ensure reproducibility .
Investigating the function of an uncharacterized protein like YOR329W-A requires a systematic experimental approach following principles of robust experimental design. Researchers should structure their investigations using the following methodological framework:
Define variables carefully:
Independent variables: Genetic modifications, environmental conditions, interacting partners
Dependent variables: Growth rates, gene expression patterns, metabolic outputs
Control variables: Wild-type strains, standard growth conditions
Design experimental treatments with incrementally increasing complexity:
Gene deletion/knockout studies using CRISPR-Cas9
Overexpression studies with inducible promoters
Domain mutation studies to assess structure-function relationships
Protein localization studies using fluorescent tags
Implement between-subjects design for strain comparisons and within-subjects design for time-course studies
Control for extraneous variables by standardizing:
Media composition and pH
Growth temperature and aeration
Cell density and growth phase
Genetic background of strains
Apply randomization and replication:
Minimum of 3 biological replicates
Multiple technical replicates per condition
Random assignment of samples to analytical runs
This structured approach ensures that causal relationships can be established between genetic/environmental manipulations and observed phenotypes, leading to reliable functional characterization of YOR329W-A .
When facing contradictory functional data for YOR329W-A, researchers should implement a systematic resolution strategy:
Data validation and quality assessment:
Re-examine raw data and statistical analyses
Verify reagent and strain authenticity
Assess experimental conditions for hidden variables
Contextual analysis:
Investigate strain-specific effects (genetic background differences)
Examine environmental condition variations (media, temperature, growth phase)
Consider potential post-translational modifications affecting function
Integration of multiple methodologies:
Combine genetic approaches (knockouts, point mutations)
Apply orthogonal biochemical assays
Implement in vivo and in vitro studies in parallel
Computational modeling:
Use structural predictions to inform hypotheses
Apply systems biology approaches to place contradictions in pathway context
Model protein interactions under different conditions
Collaborative verification:
Engage independent laboratories for verification
Standardize protocols across research groups
Conduct blind studies to minimize bias
This systematic approach transforms contradictory data from a research obstacle into an opportunity for deeper insights into the contextual functioning of YOR329W-A. Document all reconciliation attempts in publications to advance methodological approaches in the field .
Optimizing high-throughput screening for YOR329W-A interaction partners requires careful experimental design and methodological considerations:
Primary screening methods selection:
Yeast two-hybrid (Y2H) with YOR329W-A as both bait and prey
Affinity purification-mass spectrometry (AP-MS) using tagged YOR329W-A
Protein microarrays with purified YOR329W-A as probe
Experimental design optimizations:
Use structured factorial design to test multiple conditions
Include appropriate positive and negative controls
Implement counter-screening to eliminate false positives
Data analysis pipeline development:
Apply statistical filters (p-value < 0.05, fold change > 2.0)
Use visualization tools to identify interaction clusters
Implement machine learning algorithms to prioritize candidates
Validation strategy implementation:
Select diverse candidates representing different functional categories
Confirm interactions using orthogonal methods (co-immunoprecipitation, FRET)
Perform functional studies to establish biological relevance
Screening Method | Advantages | Limitations | Validation Approach |
---|---|---|---|
Yeast Two-Hybrid | In vivo detection, scalable | High false positive rate | Co-IP, BiFC |
AP-MS | Detects complexes, quantitative | Requires optimal conditions | Reciprocal pulldowns |
Protein Microarrays | High-throughput, direct binding | In vitro only | SPR, ITC |
BioID | Captures transient interactions | Requires in-cell expression | Microscopy co-localization |
This integrated approach maximizes the discovery potential while minimizing false positives, ultimately leading to a reliable interactome map for YOR329W-A .
Determining the subcellular localization of YOR329W-A requires a multi-technique approach to ensure accurate characterization:
Fluorescent protein fusion constructs:
C-terminal and N-terminal GFP/mCherry fusions should both be tested
Expression under native promoter is preferable to avoid artifacts
Control experiments with known localization markers must be included
Time-course imaging during different growth phases is recommended
Immunofluorescence microscopy:
Requires generation of specific antibodies or use of tag-specific antibodies
Fixation protocols should be optimized for yeast cells (4% paraformaldehyde)
Permeabilization conditions must preserve cellular structures
Co-staining with organelle markers provides confirmation
Subcellular fractionation:
Differential centrifugation followed by Western blotting
Density gradient separation for finer resolution
Multiple fraction markers should be used to confirm separation quality
Proximity-based labeling:
BioID or APEX2 fusions to identify proximal proteins
Helps confirm localization while also identifying interaction partners
The combination of these techniques provides stronger evidence than any single method, as each has specific strengths and limitations. Researchers should report any differences observed between methods and investigate potential causes of discrepancies, such as tag interference with localization signals or condition-dependent localization patterns .
Designing genetic knockouts for studying YOR329W-A function requires careful consideration of the genomic context and potential off-target effects:
Knockout strategy selection:
Complete ORF deletion via homologous recombination
CRISPR-Cas9 targeted disruption
Conditional systems for essential genes (if YOR329W-A proves essential)
Design considerations:
Verify absence of overlapping genes or regulatory elements
Check for potential effects on neighboring genes
Design specific primers for knockout confirmation
Include selectable markers that minimally affect cellular physiology
Validation requirements:
PCR verification of correct insertion/deletion
RT-qPCR confirmation of transcript absence
Western blotting (if antibodies available)
Whole genome sequencing to check for off-target effects
Control strain creation:
Generate marker-only integration controls
Create complementation strains with wild-type YOR329W-A
Develop point mutant libraries for structure-function analysis
Phenotypic analysis matrix:
Condition Category | Specific Conditions | Measurements | Controls |
---|---|---|---|
Growth conditions | Various carbon sources, temperatures, pH | Growth rate, lag phase, yield | Wild-type, marker control |
Stress conditions | Oxidative, osmotic, temperature | Survival rate, stress gene expression | Known stress-sensitive mutants |
Cell cycle | Synchronization, cell division | Cell size, budding index, cycle progression | Established cell cycle mutants |
Metabolism | Fermentation, respiration | Metabolite profiles, enzyme activities | Known metabolic mutants |
This comprehensive approach ensures that the functional characterization of YOR329W-A through knockout studies is rigorous and accounts for potential confounding factors .
Post-translational modifications (PTMs) can significantly impact protein function, and analyzing them for YOR329W-A requires specialized methodologies:
Mass spectrometry-based approaches:
Enrichment strategies for specific PTMs (phosphopeptides, glycopeptides)
Multiple fragmentation techniques (CID, ETD, HCD) for comprehensive coverage
Quantitative analysis using SILAC or TMT labeling
Targeted MS methods (PRM, MRM) for specific site monitoring
Site-directed mutagenesis workflow:
In silico prediction of PTM sites using algorithms specific to each modification
Systematic mutation of predicted sites (Ser/Thr/Tyr to Ala for phosphorylation)
Functional analysis of mutants under relevant conditions
Rescue experiments with phosphomimetic mutations (Ser/Thr to Asp/Glu)
PTM-specific antibodies and staining:
Western blotting with modification-specific antibodies
Phos-tag SDS-PAGE for phosphorylation analysis
Pro-Q Diamond staining for phosphoprotein detection
Periodic acid-Schiff staining for glycosylation
Temporal dynamics analysis:
Time-course studies during different growth phases
Stress response time points
Cell cycle synchronization
For YOR329W-A specifically, researchers should focus on phosphorylation and acetylation analysis, as these modifications are common regulatory mechanisms in yeast proteins. The hydrophobic character of the protein sequence suggests that it may be membrane-associated, so lipid modifications should also be investigated .
Analyzing global expression data to elucidate YOR329W-A function requires a systematic approach combining bioinformatics and experimental validation:
Experimental design for transcriptomics/proteomics:
Compare YOR329W-A knockout vs. wild-type under multiple conditions
Include time-course analysis during stress responses
Analyze YOR329W-A overexpression effects on global expression patterns
Primary data analysis pipeline:
Quality control and normalization of raw data
Differential expression analysis (DESeq2, limma)
Multiple testing correction (Benjamini-Hochberg FDR)
Fold change thresholds (typically ≥1.5-fold with p<0.05)
Secondary analysis for functional insights:
Gene Ontology (GO) enrichment analysis
Pathway analysis (KEGG, Reactome)
Transcription factor binding site analysis
Protein-protein interaction network construction
Integration of multiple omics datasets:
Correlation of transcriptome and proteome changes
Integration with metabolomics data
Cross-referencing with epigenomic data
Validation experiments:
RT-qPCR confirmation of key differentially expressed genes
ChIP assays to verify transcription factor associations
Reporter assays for pathway activation
This integrated approach allows researchers to move beyond simple lists of differentially expressed genes to develop testable hypotheses about YOR329W-A function in specific cellular processes or stress responses. The temporal and conditional aspects of gene expression changes are particularly informative for uncharacterized proteins .
Experimental design considerations for statistical robustness:
Power analysis to determine sample size (typically n≥3 biological replicates)
Randomization and blocking to control for batch effects
Inclusion of appropriate controls for normalization
Statistical test selection based on data characteristics:
Data Type | Appropriate Tests | Assumptions | Alternatives for Non-parametric Data |
---|---|---|---|
Continuous measures (growth rate) | t-test, ANOVA, linear regression | Normality, homoscedasticity | Mann-Whitney U, Kruskal-Wallis |
Categorical outcomes (survival) | Chi-square, Fisher's exact | Independent observations | N/A |
Time-course data | Repeated measures ANOVA, mixed models | Sphericity, compound symmetry | Generalized estimating equations |
High-dimensional data | False discovery rate correction | Independence of tests | Permutation testing |
Advanced analytical approaches:
Principal Component Analysis (PCA) for dimensionality reduction
Hierarchical clustering for pattern identification
Machine learning for predictive modeling (Random Forest, SVM)
Bayesian approaches for incorporating prior knowledge
Visualization strategies:
Box plots with individual data points for transparency
Volcano plots for highlighting significant changes
Heatmaps for multivariate pattern visualization
Network graphs for interaction data
Reporting requirements:
Clear description of statistical methods used
Explicit statement of hypotheses tested
Comprehensive reporting of all statistical parameters
Availability of raw data and analysis code
Integrating structural predictions with functional data provides deeper insights into YOR329W-A's biological role:
Structural prediction methodology:
Sequence-based secondary structure prediction (PSIPRED, JPred)
Homology modeling if templates exist (SWISS-MODEL, Phyre2)
Ab initio modeling for novel folds (Rosetta, AlphaFold)
Membrane topology prediction (TMHMM, Phobius)
Functional domain analysis:
Conserved domain searches (CDD, Pfam)
Motif identification (ELM, ScanProsite)
Binding site prediction (3DLigandSite, COACH)
Molecular dynamics simulations for flexibility analysis
Structure-function relationship analysis:
Map mutations to structural models
Correlate conservation patterns with structural features
Predict functional residues based on structural context
Design targeted mutations based on structural insights
Experimental validation of structural predictions:
Circular dichroism to verify secondary structure content
Limited proteolysis to identify domain boundaries
Site-directed mutagenesis of predicted functional residues
Crosslinking studies to validate interaction interfaces
Integrative modeling workflow:
Begin with sequence-based predictions
Refine models using experimental constraints
Iteratively improve models as new data becomes available
Document confidence levels for different regions of the model
Based on the available sequence data, YOR329W-A appears to have hydrophobic regions that may indicate membrane association or protein-protein interaction domains. Researchers should systematically test the functional significance of these features through targeted mutations and localization studies .